
Wockhardt to exit US generic pharmaceutical segment
Mumbai: Wockhardt has announced a significant strategic realignment of its U.S. business, marking an exit from the generic pharmaceutical segment in the United States. The exit paves the way for deeper focus and investment in its advanced product portfolio …